OHB (OHB.DE) stock: key figures, P/E, revenue and dividend
Industrials · Germany · ISIN DE0005936124
OHB financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.00 bn EUR | 1.22 bn EUR |
| Gross profit | 174.00 m EUR | 142.00 m EUR |
| Operating income | 17.50 m EUR | 75.59 m EUR |
| EBIT | 12.00 m EUR | 66.00 m EUR |
| Net income | 0.00 EUR | 49.00 m EUR |
| Diluted EPS – continuing operations | -0.01 EUR | 2.72 EUR |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About OHB
OHB SE operates as a space and technology company in Germany, rest of Europe, and internationally. The company operates through Space Systems, Access to Space, and Digital segments. The Space Systems segment focuses on developing and executing space projects. This segment primarily develops and manufactures near-earth orbit and geostationary satellites for navigation, science, communication, earth and weather observation and reconnaissance, including scientific payloads; explores, studies areas of security and reconnaissance with a focus on the moon, asteroids, and Mars. The Access to Space segment is involved in assembling and developing aviation and space products; and other industrial activities. The Digital segment provides mechatronic systems for antennas, and telescopes; and engages in the operation of purchasing rocket launches and the provision of IT services. OHB SE was incorporated in 1993 and is headquartered in Bremen, Germany.
More stocks
- Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336.SS)
- Haseko Corp (1808.T)
- Goke Microelectronics Co Ltd (300672.SZ)
- WARRIOR MET COAL, INC. (HCC)
- Hangzhou Great Star Industrial Co Ltd (002444.SZ)
- Indorama Ventures PCL (IVL.BK)
- Interpump Group SpA (IP.MI)
- GENTEX CORP (GNTX)
- RemeGen Co Ltd (9995.HK)
- TIZA Information Industry Corporation Inc (300209.SZ)
- GEK Terna SA (GEKTERNA.AT)
- Sk Biopharmaceuticals Co Ltd (326030.KS)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.